empiricalventures.vcCrawled Oct 25, 2026
The Empirical Ventures portfolio: 35 deep-tech and life-science companies across life sciences, deep tech, advanced materials, robotics and energy.
The Empirical Venture Studio backs scientists to take breakthrough research all the way, from the lab bench to the world. A manifesto for the vanguard of science.
The intersection of media and venture capital, focused on scientific breakthroughs: films, funding news and writing from Empirical Ventures and Dr Ben Miles.
Empirical Ventures backs Proxima Fusion, Europe's leading fusion company
Empirical Ventures leads £2m seed round in Healome
Nuclear Turbines raises 15m pre-seed to put a reactor next to the factory
Neuronostics raises £3m to scale its epilepsy diagnostic
We invest in exceptional founders working on cutting-edge technologies across deep tech and life sciences.
Empirical Ventures is led by Dr Ben Miles and Dr Johnathan Matlock, scientists and operators who have discovered, built and exited before.
Empirical Ventures is a specialist VC and venture builder backing the world's boldest early-stage deep-tech and life-science companies, built by scientists.
Empirical Ventures is a specialist VC and venture builder backing the world's boldest early-stage deep-tech and life-science companies, built by scientists.
How this website uses cookies and browser storage. We keep it minimal, with no tracking.
How Empirical Ventures collects, uses and protects your personal data.
Nuclear Turbines secures £15 million in pre-seed funding to develop compact nuclear reactors deployable at industrial sites like factories or data centers. The Manchester-based startup, co-founded by Dr. Jeremy Owston (ex-BAE Systems) and Professor Tim Abram (University of Manchester), aims to integrate these reactors directly into energy-intensive operations. The funding round marks the company’s first major investment, backed by UK deep-tech fund Empirical Ventures.
Jul 2026empiricalventures.vcNews article
Healome secures £2 million in seed funding from Empirical Ventures to advance its first-in-class ocular fluid-gel therapy. The biotechnology company focuses on developing treatments for eye conditions using innovative gel-based formulations. This investment supports early-stage research and clinical development efforts.
Jul 2026empiricalventures.vcNews article
Empirical Ventures invests in Proxima Fusion, a Munich-based stellarator fusion company. The startup is Europe’s leading fusion developer and the first spin-out from the Max Planck Institute for Plasma Physics. Proxima Fusion focuses on advancing stellarator technology for clean energy solutions.
Jul 2026empiricalventures.vcNews article
Neuronostics secures £3 million in funding from Empirical Ventures to expand BioEP, a clinical decision-support tool designed to improve epilepsy diagnosis. The tool aids healthcare providers in assessing patient cases more accurately. The investment will support scaling operations and further development of the diagnostic platform.
Jun 2026empiricalventures.vcNews article
